We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$3.08B
AUM Growth
+$429M
Cap. Flow
+$303M
Cap. Flow %
9.83%
Top 10 Hldgs %
12.86%
Holding
1,336
New
161
Increased
732
Reduced
335
Closed
102

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$47.7M
2
V icon
Visa
V
+$21.2M
3
CVX icon
Chevron
CVX
+$16.5M
4
PEP icon
PepsiCo
PEP
+$12.2M
5
ABT icon
Abbott
ABT
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 24.11%
2 Healthcare 14.19%
3 Consumer Discretionary 11.25%
4 Industrials 10.72%
5 Financials 10.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPK icon
1101
Graphic Packaging
GPK
$3.53B
$204K 0.01%
+7,995
New +$188K
AME icon
1102
Ametek
AME
$58.7B
$203K 0.01%
1,397
-55,155
-98% -$7.84M
NMR icon
1103
Nomura Holdings
NMR
$28.7B
$203K 0.01%
53,310
+15,108
+40% +$59.6K
BASE
1104
DELISTED
Couchbase
BASE
$202K 0.01%
14,396
+3,154
+28% +$46.5K
JKHY icon
1105
Jack Henry & Associates
JKHY
$11B
$202K 0.01%
1,342
-27
-2% -$4.51K
BEEM icon
1106
Beam Global
BEEM
$26M
$202K 0.01%
12,684
+1,384
+12% +$22.9K
REZI icon
1107
Resideo Technologies
REZI
$3.68B
$201K 0.01%
+10,975
New +$198K
DRH icon
1108
Diamondrock Hospitality Co
DRH
$2.48B
$199K 0.01%
24,531
-33,916
-58% -$294K
IBRX icon
1109
ImmunityBio
IBRX
$8.05B
$195K 0.01%
107,144
-2,954
-3% -$9.19K
BEKE icon
1110
KE Holdings
BEKE
$18.8B
$194K 0.01%
+10,319
New +$191K
TEVA icon
1111
Teva Pharmaceuticals
TEVA
$42.5B
$194K 0.01%
21,951
+2,655
+14% +$26.3K
EMBJ
1112
Embraer S.A. ADS
EMBJ
$12.8B
$193K 0.01%
+11,780
New +$157K
XHR
1113
Xenia Hotels & Resorts
XHR
$1.73B
$193K 0.01%
14,709
-145
-1% -$2K
TGS icon
1114
Transportadora de Gas del Sur
TGS
$4.29B
$190K 0.01%
18,514
-36
-0.2% -$388
LYG icon
1115
Lloyds Banking Group
LYG
$88.8B
$189K 0.01%
81,679
+29,142
+55% +$70.5K
VNET
1116
VNET Group
VNET
$2.12B
$186K 0.01%
57,513
+426
+0.7% +$2.08K
OTLY
1117
Oatly Group
OTLY
$411M
$182K 0.01%
3,751
+1,249
+50% +$58.3K
MPT
1118
Medical Properties Trust
MPT
$2.51B
$178K 0.01%
21,676
+637
+3% +$7.03K
YALA
1119
Yalla Group
YALA
$818M
$178K 0.01%
45,116
+2,948
+7% +$12.9K
UNIT
1120
Uniti Group
UNIT
$2.28B
$177K 0.01%
49,861
-238,462
-83% -$1.26M
PRDO icon
1121
Perdoceo Education
PRDO
$1.98B
$176K 0.01%
+13,073
New +$183K
ASTS icon
1122
AST SpaceMobile
ASTS
$20.9B
$175K 0.01%
34,447
+4,430
+15% +$25.5K
BYND icon
1123
Beyond Meat
BYND
$216M
$170K 0.01%
+10,463
New +$172K
DNA icon
1124
Ginkgo Bioworks
DNA
$506M
$168K 0.01%
3,161
+1,904
+151% +$121K
VIP
1125
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$28.7M
$166K 0.01%
36,963
+21,331
+136% +$129K

Similar funds

Vident Investment Advisory's Q1 2023 Portfolio in Review

As of Q1 2023, Vident Investment Advisory held 1,336 positions worth $3.08B, up 16% from $2.65B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Vident Investment Advisory deployed $303M of net new capital in Q1 2023, opening 161 new positions and adding to 732 existing holdings. Its largest new stake was Hormel Foods: 165,491 shares worth $6.6M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Philip Morris, an estimated $17.1M trimmed.

  • Vident Investment Advisory's largest Q1 2023 buy was Hormel Foods: 165,491 shares worth $6.6M.
  • Vident Investment Advisory added most to Apple in Q1 2023, an estimated $47.7M increase.
  • Vident Investment Advisory's biggest Q1 2023 reduction was Philip Morris, cutting an estimated $17.1M.
  • Vident Investment Advisory fully exited Coherent in Q1 2023, selling an estimated $5.89M.
  • Vident Investment Advisory's ten largest holdings make up 13% of its $3.08B portfolio in Q1 2023.
  • Vident Investment Advisory opened 161 new positions and closed 102 in Q1 2023.
  • Vident Investment Advisory's portfolio value rose 16% quarter-over-quarter to $3.08B.

Based on Vident Investment Advisory's 13F filing for Q1 2023, filed 15 May 2023.